Vassanelli C, Menegatti G, Rizzotti P, Cocco C, Plebani M, Burlina A, Zardini P
G Ital Cardiol. 1985 Feb;15(2):128-34.
To define the optimal diagnostic strategy for acute myocardial infarction, 225 patients with suspected myocardial infarction were studied by serial (3 hour intervals) sampling for CK and CK-MB enzyme activity. In 12 patients the diagnosis of myocardial infarction was rejected. In the remaining 213 the myocardial infarction was transmural in 183 (anterior in 79, postero-inferior in 95, anterior and inferior in 9), non transmural in 30. In these patients the mean increase of enzyme activity, the time to pick activity and the infarct size (Sobel method) were measured. The best diagnostic sensitivity in the early phases of myocardial infarction was obtained by the combined use of CK and CK-MB determinations (95.9% of the diagnosis at 9 hours after the acute event). However the percent of positivity of CK & CK-MB values occurred significantly (p less than 0.01) later in non transmural (4.3% at 3, 34.7% at 6 and 86.9% at 9 hours after the onset of the chest pain) than in transmural myocardial infarction (25.2% at 3, 54.4% at 6 and 97.6% at 9 hours) and among these in inferior as compared to anterior (18.7% vs 32.2% at 3 hours, 46.8% vs 62.7% at 6 hours and 96.8% vs 98.3% at 9 hours). The CK/CK-MB ratio was of limited diagnostic value because it was increased (greater than 8) in most of the patients, either with normal or abnormal enzymes activities. Early kinetics differed in the different anatomo-clinical types of infarction. In all locations of myocardial infarction the mean enzyme activity increase was significantly correlated with the calculated enzymatic infarct size.(ABSTRACT TRUNCATED AT 250 WORDS)
为确定急性心肌梗死的最佳诊断策略,对225例疑似心肌梗死患者进行了研究,通过连续(间隔3小时)采样检测肌酸激酶(CK)和肌酸激酶同工酶(CK-MB)活性。12例患者被排除心肌梗死诊断。其余213例中,183例为透壁性心肌梗死(前壁79例,下后壁95例,前壁和下壁9例),30例为非透壁性心肌梗死。测量了这些患者的酶活性平均升高值、活性峰值时间和梗死面积(索贝尔法)。在心肌梗死早期,联合检测CK和CK-MB可获得最佳诊断敏感性(急性事件发生后9小时诊断率为95.9%)。然而,非透壁性心肌梗死患者CK和CK-MB值的阳性率出现时间显著晚于透壁性心肌梗死(胸痛发作后3小时为4.3%,6小时为34.7%,9小时为86.9%),且下壁心肌梗死患者与前壁心肌梗死患者相比,阳性率出现时间更晚(3小时分别为18.7%和32.2%,6小时分别为46.8%和62.7%,9小时分别为96.8%和98.3%)。CK/CK-MB比值的诊断价值有限,因为大多数患者(酶活性正常或异常)该比值均升高(大于8)。不同解剖临床类型梗死的早期动力学有所不同。在所有心肌梗死部位,酶活性平均升高值与计算得出的酶学梗死面积显著相关。(摘要截选至250词)